ALDH5A1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.140200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.770400E-01
Normal-vs-Stage2
4.952800E-01
Normal-vs-Stage3
3.229800E-01
Normal-vs-Stage4
4.788600E-01
Stage1-vs-Stage2
2.889700E-02
Stage1-vs-Stage3
7.863900E-03
Stage1-vs-Stage4
2.268000E-01
Stage2-vs-Stage3
1.746200E-01
Stage2-vs-Stage4
7.439000E-01
Stage3-vs-Stage4
1.542370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.333000E-01
Normal-vs-AfricanAmerican
6.427000E-01
Normal-vs-Asian
2.014800E-01
Caucasian-vs-AfricanAmerican
4.181800E-01
Caucasian-vs-Asian
5.397000E-01
AfricanAmerican-vs-Asian
1.893980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.306600E-01
Normal-vs-Female
2.231400E-01
Male-vs-Female
6.984200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.859400E-01
Normal-vs-Age(41-60Yrs)
3.990000E-01
Normal-vs-Age(61-80Yrs)
1.594350E-01
Normal-vs-Age(81-100Yrs)
5.847400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.150600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.866800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.680400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.890800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.127200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.370600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.824000E-01
Normal-vs-Daily Drinker
4.646000E-01
Normal-vs-Weekly Drinker
4.011600E-01
Normal-vs-Occasional Drinker
6.456600E-01
Normal-vs-Social Drinker
5.581000E-01
Non Drinker-vs-Daily Drinker
8.153000E-01
Non Drinker-vs-Weekly Drinker
3.222800E-01
Non Drinker-vs-Occasional Drinker
3.263400E-01
Non Drinker-vs-Social Drinker
3.031800E-01
Daily Drinker-vs-Weekly Drinker
4.485600E-01
Daily Drinker-vs-Occasional Drinker
2.832800E-01
Daily Drinker-vs-Social Drinker
2.584200E-01
Weekly Drinker-vs-Occasional Drinker
1.529250E-01
Weekly Drinker-vs-Social Drinker
1.282010E-01
Occasional Drinker-vs-Social Drinker
9.511000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.81250000014433E-07
Normal-vs-Grade 2
1.415640E-02
Normal-vs-Grade 3
1.940230E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.333500E-02
Grade 1-vs-Grade 3
5.891900E-02
Grade 1-vs-Grade 4
3.81250000014433E-07
Grade 2-vs-Grade 3
8.417000E-01
Grade 2-vs-Grade 4
1.415640E-02
Grade 3-vs-Grade 4
1.940230E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.745400E-01
Normal-vs-NonDiabetic
1.926190E-01
Diabetic-vs-NonDiabetic
8.959600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.665800E-01
Normal-vs-NoPancreatitis
2.477200E-01
Pancreatitis-vs-NoPancreatitis
3.978400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.393000E-01
Normal-vs-N1
4.931400E-01
N0-vs-N1
7.095500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.397200E-01
Normal-vs-TP53-NonMutant
8.088200E-01
TP53-Mutant-vs-TP53-NonMutant
8.15339999999942E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
